Minocycline treatment inhibits lipid peroxidation, preserves spinal cord ultrastructure, and improves functional outcome after traumatic spinal cord injury in the rat

Spine

Volumn 38, Issue 15, 2013, Pages 1253-1259

  Sonmez, Erkin ^a   Kabatas, Serdar ^a   Ozen, Ozlem ^a   Karabay, Gulten ^a   Turkoglu, Suna ^a   Ogus, Ersin ^a   Yilmaz, Cem ^b   Caner, Hakan ^a   Altinors, Nur ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Apoptosis; behavioral assessment; lipid peroxidation; minocycline; neuroprotection; traumatic spinal cord injury

Indexed keywords

BIOTIN; DEOXYURIDINE; DNA NUCLEOTIDYLEXOTRANSFERASE; GLUTATHIONE; MALONALDEHYDE; MINOCYCLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DISEASE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXPERIMENTAL STUDY; LIPID PEROXIDATION; MALE; MORBIDITY; MORTALITY; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL CORD INJURY; SPINE MOBILITY; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; HINDLIMB; HUMANS; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; LIPID PEROXIDATION; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MINOCYCLINE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES;

EID: 84879962972     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3182895587     Document Type: Article

References (19)

1. Yong VW, Wells J, Giuliani F, et al. The promise of minocycline in neurology. Lancet Neurol 2004; 3: 744-51.
2. Stirling DP, Koochesfahani KM, Steeves JD, et al. Minocycline as a neuroprotective agent. Neuroscientist 2005; 11: 308-22.
3. Kaptanoglu E, Caner HH, Surucu HS, et al. Effect of mexiletine on lipid peroxidation and early ultrastructural findings in experimental spinal cord injury. J Neurosurg 1999; 91: 200-4.
4. Teng YD, Choi H, Onario RC, et al. Minocycline inhibits contu-sion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci USA 2004; 101: 3071-6.
5. Kaptanoglu E, Caner H, Solaroglu I, et al. Mexiletine treatment-induced inhibition of caspase-3 activation and improvement of behavioral recovery after spinal cord injury. J Neurosurg Spine 2005; 3: 53-6.
6. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-10.
7. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-7.
8. Kaptanoglu E, Palaoglu S, Surucu HS, et al. Ultrastructural scor-ing of graded acute spinal cord injury in the rat J Neurosurg 2002; 97: 49-56.
9. Kaptanoglu E, Solaroglu I, Okutan O, et al. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev 2004; 27: 113-20.
10. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1-21.
11. Wells JE, Hurlbert RJ, Fehlings MG, et al. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 2003; 126: 1628-37.
12. Yrjanheikki J, Keinanen R, Pellikka M, et al. Tetracyclines inhibit microglial activation and are neuroprotective in global brain isch-emia. Proc Natl Acad Sci USA 1998; 95: 15769-74.
13. Lee SM, Yune TY, Kim SJ, et al. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J Neurotrauma 2003; 20: 1017-27.
14. Pinzon A, Marcillo A, Quintana A, et al. A re-assessment of mino-cycline as a neuroprotective agent in a rat spinal cord contusion model. Brain Res 2008; 1243: 146-51.
15. Garrido-Mesa N, Zarzuelo A, Gálvez J. What is behind the non-antibiotic properties of minocycline? Pharmacol Res 2013; 67: 18-30.
16. Fagan SC, Edwards DJ, Borlongan CV, et al. Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection. Exp Neurol 2004; 186: 248-51.
17. Colovic M, Caccia S. Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat J Chromatogr B Analyt Technol Biomed Life Sci 2003; 791: 337-43.
18. Xu L, Fagan SC, Waller JL, et al. Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol 2004; 4: 7.
19. Morimoto N, Shimazawa M, Yamashima T, et al. Minocycline inhibits oxidative stres and decreases in vitro and in vivo ischemic neuronal damage. Brain Res 2005; 1044: 8-15.